These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 37844988)

  • 21. HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021.
    Marcus U; Schink SB; Weber C
    BMC Public Health; 2023 Apr; 23(1):661. PubMed ID: 37029369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sexually transmitted diseases in people living with HIV after implementation of cost coverage of HIV pre-exposure prophylaxis by statutory health insurance in Germany.
    Schuettfort G; Groh A; Kann G; Haberl A; Herrmann E; Wetzstein N; Vehreschild MJGT; Stephan C
    HIV Med; 2023 Feb; 24(2):163-169. PubMed ID: 35859321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sexually Transmitted Infections Among Men and Transgender Women Using HIV Pre-exposure Prophylaxis in a Large Integrated Health System-A Cohort Study.
    Hechter RC; Bruxvoort KJ; Zhou H; Towner WJ; Contreras R; Schumacher CM; Grant DL; Jones J
    J Acquir Immune Defic Syndr; 2022 Sep; 91(1):1-8. PubMed ID: 35499561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany.
    Schmidt D; Kollan C; Bartmeyer B; Bremer V; Schikowski T; Friebe M; Schellberg S; Scholten S; Bickel M; Hanhoff N; Rüsenberg R; Schewe K;
    Infection; 2023 Jun; 51(3):665-678. PubMed ID: 36168098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community-engaged mHealth intervention to increase uptake of HIV pre-exposure prophylaxis (PrEP) among gay, bisexual and other men who have sex with men in China: study protocol for a pilot randomised controlled trial.
    Li C; Xiong Y; Muessig KE; Tang W; Huang H; Mu T; Tong X; Yu J; Yang Z; Sherer R; Hazra A; Lio J; Matthews DD; Fisher EB; Li L; Tucker JD
    BMJ Open; 2022 May; 12(5):e055899. PubMed ID: 35537794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population-Level Effectiveness of HIV Pre-exposure Prophylaxis Among MSM and Transgender Persons With Bacterial Sexually Transmitted Infections.
    Pagkas-Bather J; Khosropour CM; Golden MR; Thibault C; Dombrowski JC
    J Acquir Immune Defic Syndr; 2021 Jun; 87(2):769-775. PubMed ID: 33538527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
    Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B;
    Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-exposure prophylaxis and bacterial sexually transmitted infections (STIs) among gay and bisexual men.
    Hart TA; Noor SW; Berlin GW; Skakoon-Sparling S; Tavangar F; Tan D; Lambert G; Grace D; Lachowsky NJ; Jollimore J; Sang J; Parlette A; Lal A; Apelian H; Moore D; Cox J;
    Sex Transm Infect; 2023 May; 99(3):167-172. PubMed ID: 35701145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
    BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incident Cases of Sexually Transmitted Infections among Users of Pre-Exposure Prophylaxis for HIV Prevention in Honolulu, Hawai'i.
    Kiefer EM; Ross KS; Santos AC; Barney MR; McCormick TJ; Chow DC; Shikuma CM
    Hawaii J Health Soc Welf; 2021 Jul; 80(7):148-154. PubMed ID: 34278321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Latent Class Analysis of Sexual Behaviours and Attitudes to Sexually Transmitted Infections Among Gay and Bisexual Men Using PrEP.
    Traeger MW; Murphy D; Ryan KE; Asselin J; Cornelisse VJ; Wilkinson AL; Hellard ME; Wright EJ; Stoové MA
    AIDS Behav; 2022 Jun; 26(6):1808-1820. PubMed ID: 34782934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross-sectional study, Germany, 2018 and 2019.
    Koppe U; Seifried J; Marcus U; Albrecht S; Jansen K; Jessen H; Gunsenheimer-Bartmeyer B; Bremer V
    Euro Surveill; 2022 Apr; 27(14):. PubMed ID: 35393929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men.
    McManus H; Grulich AE; Amin J; Selvey C; Vickers T; Bavinton B; Zablotska I; Vaccher S; Jin F; Holden J; Price K; Yeung B; Cabrera Quichua G; Ogilvie E; McNulty A; Smith D; Guy R
    JAMA Netw Open; 2020 Dec; 3(12):e2030806. PubMed ID: 33355675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study.
    Jongen VW; Zimmermann HML; Goedhart M; Bogaards JA; Davidovich U; Coyer L; de Vries HJC; Prins M; Hoornenborg E; Schim van der Loeff MF;
    Sex Transm Infect; 2023 May; 99(3):149-155. PubMed ID: 35584898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation of pre-exposure prophylaxis programme in Spain. Feasibility of four different delivery models.
    Iniesta C; Coll P; Barberá MJ; García Deltoro M; Camino X; Fagúndez G; Díaz A; Polo R;
    PLoS One; 2021; 16(2):e0246129. PubMed ID: 33556085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data.
    Traeger MW; Guy R; Asselin J; Patel P; Carter A; Wright EJ; Grulich A; McManus H; Fairley CK; Chow EPF; McNulty A; Finlayson R; Bell C; Owen L; Marshall L; Russell D; O'Donnell D; Donovan B; Hellard ME; Stoové MA;
    Lancet Infect Dis; 2022 Aug; 22(8):1231-1241. PubMed ID: 35643090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Point-of-care testing for sexually transmitted infections and HIV pre-exposure prophylaxis among pregnant women in South Africa, 2021-2022: randomised controlled trial.
    de Voux A; Nyemba DC; Silliman M; Mashele N; Mvududu R; Myer L; Joseph Davey D
    Sex Transm Infect; 2024 Feb; 100(2):77-83. PubMed ID: 38124133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Missed opportunities for sexually transmitted infections testing for HIV pre-exposure prophylaxis users: a systematic review.
    Ong JJ; Fu H; Baggaley RC; Wi TE; Tucker JD; Smith MK; Rafael S; Falconer J; Terris-Prestholt F; Mameletzis I; Mayaud P
    J Int AIDS Soc; 2021 Feb; 24(2):e25673. PubMed ID: 33605081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of Chlamydia trachomatis and Neisseria gonorrhoeae in different anatomical sites among Pre-Exposure Prophylaxis (PrEP) users in Brazil.
    Antonini M; Vettore MV; Øgård-Repål A; de Macêdo Rocha D; de Alencar Rocha KA; Elias HC; Barufaldi F; Santana RC; Gir E; Spire B; Reis RK
    BMC Infect Dis; 2024 Feb; 24(1):260. PubMed ID: 38408940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.